A novel approach to rescue immune escape in oral squamous cell carcinoma: Combined use of interferon-γand LY294002

Oncology Reports

Volumn 25, Issue 1, 2011, Pages 181-187

  Han, Wei ^a   Pan, Hongya ^a   Jiang, Linlin ^c   Zou, Duohong ^b   Wei, Kuijie ^a   Zhang, Zhiyuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

^c Nanjing Second Hospital   (China)

Author keywords

Antigen processing machinery; Immune escape; Oral squamous cell carcinoma; Phosphoinositide 3 kinase (PI3K) AKT

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GAMMA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOSURVEILLANCE; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CHROMONES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-GAMMA; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MORPHOLINES; MOUTH NEOPLASMS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR ESCAPE;

EID: 78650719195     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001059     Document Type: Article

References (20)

1. Scully C and Bagan JV: Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes. Oral Oncol 44: 211-215, 2008.
2. Wang Z, Hu Q, Han W, et al: Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro. Int J Oral Maxillofac Surg 35: 544-550, 2006.
3. Seliger B, Maeurer MJ and Ferrone S: Antigen-processing machinery breakdown and tumor growth. Immunol Today 21: 455-464, 2000.
4. Garcia-Lora A, Algarra I and Garrido F: MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 195: 346-355, 2003.
5. Reiman JM, Kmieciak M, Manjili MH, et al: Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 17: 275-287, 2007.
6. Raghavan M, Del Cid N, Rizvi SM, et al: MHC class I assembly: out and about. Trends Immunol 29: 436-443, 2008.
7. Deshpande A, Wheeler CM, Hunt WC, et al: Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer. J Infect Dis 197: 371-381, 2008.
8. Lou Y, Basha G, Seipp RP, et al: Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival. Clin Cancer Res 14: 1494-1501, 2008.
9. Garbi N, Tiwari N, Momburg F, et al: A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression. Eur J Immunol 33: 264-273, 2003.
10. Corrias MV, Occhino M, Croce M, et al: Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression. Tissue Antigens 57: 110-117, 2001.
11. Ikeda H, Old LJ and Schreiber RD: The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 13: 95-109, 2002.
12. Setiadi AF, Omilusik K, David MD, et al: Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. Cancer Res 68: 9601-9607, 2008.
13. Morabito A, Dozin B, Salvi S, et al: Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin down-regulation in breast cancer. Hum Immunol 70: 492-495, 2009.
14. Dovhey SE, Ghosh NS and Wright KL: Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line. Cancer Res 60: 5789-5796, 2000.
15. Matsui M, Ikeda M and Akatsuka T: High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation. Biochem Biophys Res Commun 280: 1008-1014, 2001.
16. Namiki S, Nakamura T, Oshima S, et al: IRF-1 mediates upregulation of LMP7 by IFN-gamma and concerted expression of immunosubunits of the proteasome. FEBS Lett 579: 2781-2787, 2005.
17. Billiau A and Matthys P: Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 20: 97-113, 2009.
18. Martinelli S, Urosevic M, Daryadel A, et al: Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 279: 44123-44132, 2004.
19. Wang Y, Liu D, Chen P, et al: Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers. Cancer Res 68: 1136-1143, 2008.
20. Nguyen H, Ramana CV, Bayes J, et al: Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J Biol Chem 276: 33361-33368, 2001.